Synairgen Stock Soars 420% On Promise Of Inhaled COVID-19 Drug

Small Study Excites Investors

 
• By Kevin Grogan
  
Covid19_Hospital_Room
Synairgen Drug Shows Potential For Hospitalized COVID-19 Patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip